Tianjin Tasly New Resource Pharmaceutical

Tianjin Tasly New Resource Pharmaceutical is a subsidiary of the Tasly Holding Group, a leading Chinese pharmaceutical conglomerate specializing in the modernization of Traditional Chinese Medicine (TCM). The company focuses on the research, development, and large-scale production of natural medicine, health supplements, and pharmaceutical intermediates. It leverages advanced extraction and purification technologies to produce high-quality botanical extracts and finished dosage forms. Tasly New Resource plays a critical role in the parent group's supply chain, ensuring the standardization of raw materials for blockbuster products like Compound Danshen Dripping Pills. The company is committed to integrating traditional herbal wisdom with modern pharmacological standards for global markets.